血清视黄醇结合蛋白4与绝经后女性非酒精性脂肪性肝病的相关性分析

doi:10.12114/j.issn.1007-9572.2019.04.013

摘要/Abstract

摘要： 背景　绝经后女性是非酒精性脂肪性肝病（NAFLD）的危险人群，罹患该病可能导致致死性心血管疾病及其他代谢异常。但NAFLD好发于这一特定生理阶段的机制尚未完全明确。目的　检测绝经后NAFLD女性血清视黄醇结合蛋白4（RBP4）水平，探讨绝经后女性血清RBP4水平与NAFLD的关系。方法　选取2017年5—8月在浙江大学医学院附属杭州市第一人民医院体检中心接受健康体检的37~66岁女性181例。根据是否处于绝经状态和是否符合NAFLD诊断标准分为4组，即绝经前对照组（n=42）、绝经前NAFLD组（n=42）、绝经后对照组（n=36）和绝经后NAFLD组（n=61）。比较各组间血清RBP4水平，应用二分类Logistic回归分析绝经后女性血清RBP4水平与NAFLD的关系，采用受试者工作特征曲线（ROC曲线）及曲线下面积（AUC）分析血清RBP4的诊断价值。结果　绝经后NAFLD组女性血清RBP4水平高于绝经前对照组和绝经后对照组，差异有统计学意义（P<0.05）。校正混杂因素后Logistic回归分析显示，血清RBP4水平升高〔OR=1.155，95%CI（1.059，1.260），P<0.05〕是绝经后女性NAFLD发生的危险因素。血清RBP4水平预测绝经后NAFLD的ROC曲线的AUC为0.841，95%CI为（0.757，0.924），最佳截断值为25.1 mg/L，灵敏度为0.78，特异度为0.79（P<0.001）。结论　血清RBP4水平升高与绝经后女性NAFLD发生相关，对绝经后NAFLD的发生具有较好的辅助诊断价值。

关键词: 血清视黄醇结合蛋白4, 非酒精性脂肪性肝病, 绝经后期, 危险因素

Abstract: Background　Postmenopausal women are more prone to non-alcoholic fatty liver disease （NAFLD），a disease possibly leads to fatal cardiovascular disease and other metabolic disorders.However，the underlying pathogenesis of NAFLD after menopause is still unclear.Objective　To investigate the association of serum retinol-binding protein 4（RBP4） with NAFLD in postmenopausal women.Methods　A total of 181 women aged between 37 and 66 years old were recruited from the Health Checkup Department of Affiliated Hangzhou First People's Hospital，Zhejiang University School of Medicine from May to August 2017.They were divided into four groups according to the menopausal status and NAFLD diagnostic results，including premenopausal control group （n=42），premenopausal NAFLD group （n=42），postmenopausal control group （n=36） and postmenopausal NAFLD group （n=61）.Serum RBP4 was compared between the groups.Binary Logistic regression analysis was performed to explore the association between serum RBP4 and NAFLD.The diagnostic value of serum RBP4 for NAFLD was investigated by ROC curve and the area under the ROC curve （AUC） analyses.Results　The average serum RBP4 level in postmenopausal NAFLD group was significantly higher compared to premenopausal control group and postmenopausal control group（P<0.05）.After adjusting for confounding factors，Logistic regression analysis showed that elevated serum RBP4〔OR=1.155，95%CI （1.059，1.260），P<0.05〕 was an independent risk factor for NAFLD in postmenopausal period.The AUC of serum RBP4 for predicting NAFLD in postmenopausal women was 0.841〔95% CI （0.757，0.924）〕，the optimal cut-off value was 25.1 mg/L，with a sensitivity of 0.78 and a specificity of 0.79（P<0.001）.Conclusion　Elevated serum RBP4 level is positively associated with NAFLD in postmenopausal women.So serum RBP4 level has a good auxiliary diagnostic value for NAFLD in such a population.

Key words: Serum retinol-binding protein 4, Non-alcoholic fatty liver disease, Postmenopause, Risk factors

蔡泓,张治芬,仝进毅,等. 血清视黄醇结合蛋白4与绝经后女性非酒精性脂肪性肝病的相关性分析[J]. 中国全科医学, 2019, 22(4): 433-437. DOI: 10.12114/j.issn.1007-9572.2019.04.013.
CAI Hong,ZHANG Zhifen,TONG Jinyi, et al. Serum Retinol-binding Protein 4 and Non-alcoholic Fatty Liver Disease in Postmenopausal Women[J]. Chinese General Practice, 2019, 22(4): 433-437. DOI: 10.12114/j.issn.1007-9572.2019.04.013.

参考文献

［1］BRUNO A D，RODRIGUES M H，ALVARES M C，et al．Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women［J］．Climacteric，2014，17（4）：465-471．DOI：10.3109/13697137.2014.881353.
［2］RYU S，SUH B，CHANG Y，et al．Menopausal stages and non-alcoholic fatty liver disease in middle-aged women［J］．European Journal of Obstetrics & Gynecology and Reproductive Biology，2015，190：65-70．DOI：10.1016/j.ejogrb.2015.04.017.
［3］ROMEO S，VALENTI M D．Regulation of retinol-binding protein 4 and retinol metabolism in fatty liver disease［J］．Hepatology，2016，64（5）：1414-1416．DOI：10.1002/hep.28722.
［4］NAIR A K，SUGUNAN D，KUMAR M H，et al．Case-control analysis of SNPs in GLUT4，RBP4 and STRA6：association of SNPs in STRA6 with type 2 diabetes in a South Indian Population［J］．PLoS One，2010，5（7）：e11444．DOI：10.1371/journal.pone.0011444.
［5］CHEN Y，LYU P，DU M，et al．Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus［J］．Archives of Gynecology and Obstetrics，2017，296（1）：1-9.
［6］MA X，ZHOU Z，CHEN Y，et al．RBP4 functions as a hepatokine in the regulation of glucose metabolism by the circadian clock in mice［J］．Diabetologia，2016，59（2）：354-362.
［7］汤涌，张晓峰，郭忠玉，等．非酒精性脂肪性肝病合并早发冠心病患者视黄醇结合蛋白4的检测及其意义［J］．东南大学学报：医学版，2015，34（5）：766-769．DOI：10.3969/j.issn.1671-6264.2015.05.018.
TANGＹ，ZHANG X F，GUO Z Y，et al．The detection and clinical significance of retinol-binding protein 4 in patients with non-alcoholic fatty liver diseases and premature coronary artery diseases［J］．Journal of Southeast University：Medical Science Edition，2015，34（5）：766-769．DOI：10.3969/j.issn.1671-6264.2015.05.018.
［8］ZHOU Z，CHEN H，JU H，et al．Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease：a systematic review and meta-analysis［J］．Lipids in Health and Disease，2017，16（1）：180-188．DOI：10.1186/s12944-017-0566-7.
［9］中华医学会肝病学分会脂肪肝和酒精性肝病学组．非酒精性脂肪性肝病诊疗指南（2010年修订版）［J］．中华肝脏病杂志，2010，18（3）：163-166．DOI：10.3760/cma.j.issn.1007-3418.2010.03.002.
The Workshop on Fatty Liver and Alcoholic Liver Disease，Chinese Society of Hepatology．Guidelines for management of nonalcoholic fatty liver disease：an updated and revised edition［J］．Chinese Journal of Hepatology，2010，18（3）：163-166．DOI：10.3760/cma.j.issn.1007-3418.2010.03.002.
［10］中华医学会妇产科学分会绝经学组．绝经期管理与激素补充治疗临床应用指南（2012版）［J］．中华妇产科杂志，2013，48（10）：795-799．DOI：10.3760/cma.j.issn.0529-567x.2013.10.018.
Menopause Group，Chinese Society of Obstetrics and Gynecology．Guidelines for clinical application of menopausal management and hormone supplementary therapy（2012 edition）［J］．Chinese Journal of Obstetrics and Gynecology，2013，48（10）：795-799．DOI：10.3760/cma.j.issn.0529-567x.2013.10.018.
［11］GRAHAM T E，YANG Q，BLUHER M，et al．Retinol-binding protein 4 and insulin resistance in lean，obese，and diabetic subjects［J］．The New England Journal of Medicine，2006，354（24）：2552-2563．DOI：10.1056/NEJMoa054862.
［12］SUH J，KIM S，CHO G，et al．Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women［J］．Metabolism-clinical and Experimental，2010，59（1）：118-122．DOI：10.1016/j.metabol.2009.06.025.
［13］MORAESVIEIRA P M，YORE M M，DWYER P M，et al．RBP4 activates antigen-presenting cells，leading to adipose tissue inflammation and systemic insulin resistance［J］．Cell Metabolism，2014，19（3）：512-526．DOI：10.1016/j.cmet.2014.01.018.
［14］HU S，LIU Q，HUANG X，et al．Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus：a meta-analysis［J］．BMC Pregnancy and Childbirth，2016，16（1）：52．DOI：10.1186/s12884-016-0838-7.
［15］LI Y，ZHU S，LI B，et al．Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes［J］．International Urology and Nephrology，2014，46（9）：1785-1791．
［16］WU H，JIA W，BAO Y，et al．Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus［J］．Diabetes Research and Clinical Practice，2008，79
（2）：185-190．DOI：10.1016/j.diabres.2007.08.016.
［17］ZEMANY L，BHANOT S，PERONI O D，et al．Transthyretin antisense oligonucleotides lower circulating RBP4 levels and improve insulin sensitivity in obese mice［J］．Diabetes，2015，64（5）：1603-1614．DOI：10.2337/db14-0970.
［18］XIA M，LIU Y，GUO H，et al．Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway［J］．Hepatology，2013，58（2）：564-575．DOI：10.1002/hep.26227.
［19］MAHER J J．Retinol binding protein 4 and fatty liver：a direct link?［J］．Hepatology，2013，58（2）：477-479．
［20］STEFAN N，HENNIGE A M，STAIGER H，et al．High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total，subcutaneous，visceral，or intramyocellular fat in humans［J］．Diabetes Care，2007，30（5）：1173-1178．DOI：10.2337/dc06-2342.
［21］LEE S，YUEN J J，JIANG H，et al．Adipocyte-specific overexpression of retinol-binding protein 4 causes hepatic steatosis in mice［J］．Hepatology，2016，64（5）：1534-1546．
［22］LI Q，WU W，LIN H，et al．Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity：a cross-sectional study［J］．Lipids in Health and Disease，2016，15（1）：52-52．DOI：10.1186/s12944-016-0215-6.

[1]	王丽娜, 高鹏飞, 曹帆, 葛莹, 颜维, 何岱昆. 不同性别人群非酒精性脂肪性肝病患病现况及影响因素分析[J]. 中国全科医学, 2023, 26(33): 4143-4151.
[2]	孔德先, 邢煜玲, 孙文文, 张智敏, 周霏, 马慧娟. 预估葡萄糖处理率与2型糖尿病合并代谢相关脂肪性肝病的相关性研究[J]. 中国全科医学, 2023, 26(26): 3252-3258.
[3]	高哲, 段凯欣, 吕秀芹, 马慧娟, 张志梅, 宋光耀. 胰高血糖素样肽-1受体激动剂改善高果糖饮食诱导的胰岛素抵抗大鼠肝脏脂质沉积机制研究[J]. 中国全科医学, 2023, 26(21): 2639-2646.
[4]	张卓然, 于长禾, 安易, 何新, 郭一, 邓金燕, 李悦, 韩登, 皮珊珊, 贺俊芝, 陈玥, 叶永安, 杜宏波. 非酒精性脂肪性肝病临床指南和共识的质量评价及推荐意见比较研究[J]. 中国全科医学, 2023, 26(20): 2439-2446.
[5]	钱方方, 蔡珍生, 顾恬, 李昊翔, 赵丽, 杨玲, 邓霞, 袁国跃. 2型糖尿病患者血清Ectodysplasin A与非酒精性脂肪性肝病相关性研究[J]. 中国全科医学, 2023, 26(08): 911-916.
[6]	时学秀, 贠文晶, 王海旭, 赵颖颖, 杨亚楠, 孙同文. 垂体功能减退症合并肝硬化临床特征研究[J]. 中国全科医学, 2023, 26(06): 699-703.
[7]	傅伟强, 周剑波, 吴雄健, 黄才斌. 肠道菌群视角下非酒精性脂肪性肝病的治疗策略[J]. 中国全科医学, 2023, 26(06): 742-748.
[8]	刘霜雪, 李琰华, 张港玮, 赵琳. 绝经后高血压危险因素的Meta分析[J]. 中国全科医学, 2023, 26(04): 512-518.
[9]	牟利民, 张文豪, 张思平, 覃祺, 韩明展, 陈万吉, 冉建. 绝经后女性退变性膝骨关节炎疼痛与性激素水平及关节液炎性因子的相关性研究[J]. 中国全科医学, 2022, 25(29): 3652-3657.
[10]	丛方远, 薛倩, 邓利华, 朱蕗颖, 王晶桐. 非酒精性脂肪性肝病与左心室早期舒张功能不全的相关性研究[J]. 中国全科医学, 2022, 25(26): 3290-3297.
[11]	马纪林, 张雪平. 单核细胞与高密度脂蛋白胆固醇比值对社区居民非酒精性脂肪性肝病合并代谢综合征的预测价值及多因素Logistic决策树分析[J]. 中国全科医学, 2022, 25(17): 2126-2134.
[12]	卢潘萍, 廖予妹, 张喆琳. 三维超声联合恶性风险模型在绝经后出血子宫内膜癌筛查中的应用价值研究[J]. 中国全科医学, 2022, 25(14): 1724-1729,1740.
[13]	袁二伟，郭华贤，许津莉，赵文慧，赵美林，王玲玲. 晚期早产儿小于胎龄儿围生期呼吸系统并发症的危险因素研究[J]. 中国全科医学, 2021, 24(5): 581-584，602.
[14]	范尧夫，曹琳，孙洪平，许娟，包薇萍，褚晓秋. 葛根芩连汤治疗2型糖尿病合并非酒精性脂肪性肝病效果的临床研究[J]. 中国全科医学, 2021, 24(36): 4587-4592.
[15]	姚永坤，张志强，祁鸣，徐婧姗，孟瑶，李浩浩，邢文龙，张桂青. 缺血性脑卒中患者发病后不同时期生活质量的影响因素研究[J]. 中国全科医学, 2021, 24(33): 4200-4205.